Fibrin Sealant Market: Industry Trends, Share, Size and Forecast Report

Overview

Fibrin Sealant Market Introduction

The global fibrin sealant market is calculated to expand at a CAGR of over 8% during the forecast period of 2019-2026.

Fibrin sealant is a biological agent that is used to control bleeding in surgeries or injuries where ligation, suturing or cautery does not provide enough haemostasis. Fibrin is a mixture of thrombin or fibrinogen which is applied to the affected area in order to prevent haemorrhage. Additionally, a permanent factor for regional growth is also delivered by fibrin as it is also used as a delivery device. It is also an excellent blood clotting agent and it can also do tissue sealing so that it can prevent serious fluid accumulation or lymphatic leak. Considering all these properties, fibrin sealant is an ideal component for reducing fluid accumulation, ecchymoses, hematomas, swelling etc. Perhaps, it also eliminates the need for drains after rhytidectomy.

Fibrin Sealant Market Overview

Fibrin sealant market is primarily driven by increasing prevalence of invasive surgeries and traumatic injuries. Recent advancements have led to the development of biocompatible sealants which decreased the complications and allow normal movement of tissues without any interference on the functioning of the organs. Traditionally, sutures/wires/staples are used for wound sealing and they pose significant threats like tissue damage, infection and delayed the repair of the tissue. Due to the rapid advancements of technologies, traditional methods are replaced by sealants and let to the burgeoning growth of the market. Among the different types of sealants, synthetic adhesives offer high mechanical and adhesive strength. These features made the synthetic surgical sealants most attractive segment over natural sealants and expected to witness significant growth during the forecast period. All these factors have led to the potential growth of the market.

Market is dominated by the Asia Pacific due to the high prevalence of traumatic injuries and invasive surgeries. It is expected to gain more traction during the forecast period due to increasing prevalence. It is followed by North America and it dominated by the US due to high dollar opportunity. Europe is the third major shareholder in the global market due to increasing incidence during the forecast period. Latin America and Rest of World are the fast growing regions due to increasing adoption among the end user segment. They account a small fraction of the global market and expected to increase traction during the forecast period.

Fibrin Sealant market players include Covidien Inc., Baxter Healthcare Corporation, Inc., Ethicon Inc., Mallinckrodt Pharmaceuticals, Adhesys Medical GmbH, and others

Fibrin Sealant Market

Fibrin Sealant Market Segmentation

By Product Type

+ Natural Sealant

+ Synthetic Sealant

By End User

+ Hospitals

+ Clinics

+ Outpatient Centres

By Region

+ North America

+ Latin America

+ Europe

+ Asia Pacific

+ Rest of the World

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global Fibrin Sealant Market by Product Type, by End User, by Region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies